SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-007953
Filing Date
2020-05-07
Accepted
2020-05-07 16:17:18
Documents
60
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 497623
2 ex31-1.htm EX-31.1 18248
3 ex31-2.htm EX-31.2 18431
4 ex32-1.htm EX-32.1 6891
5 ex32-2.htm EX-32.2 6969
  Complete submission text file 0001493152-20-007953.txt   2780005

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE prvb-20200331.xml EX-101.INS 428089
7 XBRL SCHEMA FILE prvb-20200331.xsd EX-101.SCH 37062
8 XBRL CALCULATION FILE prvb-20200331_cal.xml EX-101.CAL 38803
9 XBRL DEFINITION FILE prvb-20200331_def.xml EX-101.DEF 118627
10 XBRL LABEL FILE prvb-20200331_lab.xml EX-101.LAB 238088
11 XBRL PRESENTATION FILE prvb-20200331_pre.xml EX-101.PRE 197540
Mailing Address P.O. BOX 666 OLDWICK NJ 08858
Business Address P.O. BOX 666 OLDWICK NJ 08858 908-428-9136
Provention Bio, Inc. (Filer) CIK: 0001695357 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38552 | Film No.: 20856666
SIC: 2834 Pharmaceutical Preparations